These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37967403)

  • 41. Immune system alterations in patients with inflammatory bowel disease during remission.
    Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
    Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.
    Buchanan J; Wordsworth S; Ahmad T; Perrin A; Vermeire S; Sans M; Taylor J; Jewell D
    J Crohns Colitis; 2011 Aug; 5(4):301-16. PubMed ID: 21683300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Anti-tumour Necrosis Factor Alpha Agents: A Systematic Review and Meta-analysis.
    Yang C; Huang J; Huang X; Huang S; Cheng J; Liao W; Chen X; Wang X; Dai S
    J Crohns Colitis; 2018 Aug; 12(9):1042-1052. PubMed ID: 29762681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.
    Siegel CA; Marden SM; Persing SM; Larson RJ; Sands BE
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):874-81. PubMed ID: 19558997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low Risk of Lymphoma in Pediatric Patients Treated for Inflammatory Bowel Disease.
    Egberg MD; Zhang X; Smitherman AB; Kappelman MD
    Am J Gastroenterol; 2023 Feb; 118(2):354-359. PubMed ID: 36219181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory bowel disease surgery in the biologic era.
    Ferrari L; Krane MK; Fichera A
    World J Gastrointest Surg; 2016 May; 8(5):363-70. PubMed ID: 27231514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study.
    Cohen NA; Plevris N; Kopylov U; Grinman A; Ungar B; Yanai H; Leibovitzh H; Isakov NF; Hirsch A; Ritter E; Ron Y; Shitrit AB; Goldin E; Dotan I; Horin SB; Lees CW; Maharshak N
    United European Gastroenterol J; 2020 Nov; 8(9):1076-1085. PubMed ID: 32807038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paediatric inflammatory bowel disease in New Zealand.
    Yap J; Wesley A; Mouat S; Chin S
    N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Inflammatory bowel diseases and lymphoma].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Feb; 82(2):185-9. PubMed ID: 15185593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Finger clubbing in inflammatory bowel disease: association with upper small bowel lesions and need of surgery in Crohn's disease.
    Romeo S; Neri B; Mossa M; Calabrese E; Lolli E; Sena G; Gesuale C; Chiaramonte C; Biancone L
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):844-851. PubMed ID: 33136723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?
    Andrews JM; Travis SP; Gibson PR; Gasche C
    Aliment Pharmacol Ther; 2009 Mar; 29(5):459-69. PubMed ID: 19077129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Peyrin-Biroulet L; Arkkila P; Armuzzi A; Danese S; Guardiola J; Jahnsen J; Lees C; Louis E; Lukáš M; Reinisch W; Roblin X; Jang M; Byun HG; Kim DH; Lee SJ; Atreya R
    BMC Gastroenterol; 2022 Jun; 22(1):291. PubMed ID: 35676620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-World Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn's Disease at a Tertiary Referral Center.
    Hoffmann P; Krisam J; Stremmel W; Gauss A
    Dig Dis; 2019; 37(1):33-44. PubMed ID: 30134234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study.
    Marin-Jimenez I; Bastida G; Forés A; Garcia-Planella E; Argüelles-Arias F; Sarasa P; Tagarro I; Fernández-Nistal A; Montoto C; Aguas M; Santos-Fernández J; Bosca-Watts MM; Ferreiro R; Merino O; Aldeguer X; Cortés X; Sicilia B; Mesonero F; Barreiro-de Acosta M
    BMJ Open Gastroenterol; 2020; 7(1):e000351. PubMed ID: 32337054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum.
    Bern EM; Bousvaros A
    Expert Rev Clin Immunol; 2013 Feb; 9(2):117-27. PubMed ID: 23390943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Case Report of Follicular Lymphoma in a Crohn's Disease Patient Treated With Azathioprine.
    Kottavadakkeel N; Farzina R; Rajaram A; Mannath S; Sunil A
    Cureus; 2023 Dec; 15(12):e50839. PubMed ID: 38125685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.